Report cover image

Biosplice Therapeutics, Inc. - Strategic SWOT Spotlight

Publisher Quaintel Research
Published Aug 27, 2024
Length 50 Pages
SKU # QTELR19119629

Description

Biosplice Therapeutics, Inc. - Strategic SWOT Spotlight


Biosplice Therapeutics, Inc. - Strategic SWOT Spotlight is a comprehensive and easily accessible overview of The Biosplice Therapeutics, Inc.'s business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, Competitive Landscape and latest events.

Key Highlights

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a biotechnology company that focuses on developing innovative therapies for diseases with high unmet medical needs. The company's main offering is its proprietary platform technology, Wnt pathway modulation, which targets the underlying cause of various diseases such as osteoarthritis, alopecia, and degenerative disc disease. Through this technology, Biosplice Therapeutics aims to provide effective treatments for these conditions, improving the quality of life for patients. Additionally, the company also offers a pipeline of potential therapies in various stages of development, including clinical trials for osteoarthritis and androgenetic alopecia. Biosplice Therapeutics is committed to advancing the field of regenerative medicine and providing hope for patients suffering from debilitating diseases. Founded in 2008, the company is headquartered in San Diego, California, United States.

Biosplice Therapeutics, Inc. in the News:-
  • 18-Apr-2024 - Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results
  • 08-Mar-2024 - Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program
  • 13-Nov-2023 - Biosplice Presents Successful Structure and Pain Results from Completed Phase 3 Long-Term Extension Clinical Trial for Lorecivivint for the Treatment of Knee Osteoarthritis
  • 11-Nov-2022 - Biosplice Announces Data from Recent Clinical Trials in Knee Osteoarthritis and the Initiation of a New Phase 3 Trial
  • 09-Sep-2022 - Biosplice Therapeutics Announced New Clinical Data for Cirtuvivint (SM08502) at the European Society for Medical Oncology Meeting
Scope

Company Fundamentals:- These fundamentals offer valuable insights into Biosplice Therapeutics, Inc.'s operations, geographical presence, products and services, ESG spotlight, Corporate Strategy, Business Description and SWOT spotlight, aiding in a comprehensive understanding of the organization.

Reasons to Buy
  • Helicopter view of company's internal and external factors through SWOT analysis - Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers. - Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations. - Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Table of Contents

50 Pages
Table of Contents
Tables
Charts
Biosplice Therapeutics, Inc. - Key Company Facts
Biosplice Therapeutics, Inc. - Company Description
Biosplice Therapeutics, Inc. - Top Executives
Biosplice Therapeutics, Inc. - Head Office & Locations
Head Office - Country
Biosplice Therapeutics, Inc. - Products and Services
Products
Services
Biosplice Therapeutics, Inc. - Corporate Strategy
Biosplice Therapeutics, Inc. - Business Description
Dermatology
Oncology
Osteoarthritis
Biosplice Therapeutics, Inc. - ESG Spotlight
Environment
Social
Corporate Governance
Biosplice Therapeutics, Inc. - SWOT Spotlight
Overview
Strengths
Weaknesses
Opportunities
Threats
Competing Players
Snapshot of Competing Players
Click Therapeutics Inc
Key Company Facts
Company Description
Terray Therapeutics, Inc.
Key Company Facts
Company Description
Relay Therapeutics, Inc.
Key Company Facts
Company Description
Key Financials:
Maze Therapeutics, Inc.
Key Company Facts
Company Description
Tango Therapeutics, Inc
Key Company Facts
Company Description
Key Financials:
Biosplice Therapeutics, Inc. - In the News
18-Apr-2024- Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results
08-Mar-2024- Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program
13-Nov-2023- Biosplice Presents Successful Structure and Pain Results from Completed Phase 3 Long-Term Extension Clinical Trial for Lorecivivint for the Treatment of Knee Osteoarthritis
11-Nov-2022- Biosplice Announces Data from Recent Clinical Trials in Knee Osteoarthritis and the Initiation of a New Phase 3 Trial
09-Sep-2022- Biosplice Therapeutics Announced New Clinical Data for Cirtuvivint (SM08502) at the European Society for Medical Oncology Meeting
17-Nov-2021- First Subject Dosed in Biosplice Therapeutics Phase 1b Clinical Trial in Oncology
15-Sep-2021- Biosplice Licenses Development and Commercialization Rights for Lorecivivint, a Novel Phase 3 Osteoarthritis Drug Candidate, to Haisco for the People's Republic of China
15-Sep-2021- Haisco to pay $140M to get the ball rolling on Biosplice's phase 3 osteoarthritis drug in China
22-Jul-2021- Biosplice Publishes Phase 2B Lorecivivint Analysis Showing Clinically Meaningful Benefits to Knee Osteoarthritis Patients
21-Jun-2021- Dave Johnson Joins Biosplice Therapeutics Board of Directors
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Research Methodology
Disclaimer
Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us